|
|||||
A collaboration of Mount Sinai medical center, drug maker Sanofi, and data science company Sema4 aims to track people with asthma for 5 years to help develop personalized treatments for the disease. . . . → Read More: Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study 
Chip devices with human immune system and stem cells are among the cargo set for launch today to the International Space Station. . . . → Read More: Immune Cell Chips to Launch into Space for Microgravity Tests 
The Food and Drug Administration identified a public database of genomics and diseases as a resource to assess new diagnostics tests using genetic data for precision medicine. . . . → Read More: FDA Identifies Database to Evaluate Precision Diagnostics 
Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year. . . . → Read More: Trial Results Show Gene Transfers Reverse Sickle Cell Disease 
Electrodes sent into a blood vessel in the brain with a catheter and stent are shown in tests with sheep to stimulate muscles in the animals’ faces and limbs. . . . → Read More: Electrode in Brain Blood Vessel Shown to Stimulate Body Muscles 
An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas. . . . → Read More: Janssen Licensing Cancer Antibodies in $1.8B Deal 
Editas Medicine received the go-ahead to conduct a clinical trial using the genome editing technique Crispr. . . . → Read More: Recap – Editas Medicine Advances Crispr Therapy  Comments are closed  New products, Regulations  biomedical, biotechnology, engineering, entrepreneurs, life sciences, physical sciences 
While much attention is focused on the continuing AIDS and HIV crisis in Africa, countries in Eastern Europe are also facing growing numbers of HIV infections. . . . → Read More: Infographic – HIV Infections Growing in Eastern Europe 
The company developing a treatment for a rare inherited eye disease using the genome editing technique Crispr received authorization from the Food and Drug Administration to begin clinical trials. . . . → Read More: Trials OK’d for Inherited Eye Disease Therapy with Crispr 2 comments - (Comments are closed) New products biomedical, biotechnology, clinical trials, FDA, genomics, licensing, life sciences, pharmaceuticals 
A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer. . . . → Read More: Project to Catalog Precision Lung Cancer Immunotherapies 5 comments - (Comments are closed) Finance, Joint ventures/collaborations biomedical, cancer, clinical trials, Europe, genomics, grant, life sciences, mathematics, pharmaceuticals, U.K. |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
